Meeting
2019 ASCO Annual Meeting
Correlation between NDRG1 gene polymorphism and neuropathy (N) in metastatic breast cancer (MBC) patients (pts) enrolled in the PAINTER study (Polymorphism And INcidence of Toxicity in ERibulin treatment).
Authors
Nicla Maria La Verde
Department of Oncology ASST Fatebenefratelli Sacco P.O. Fatebenefratelli, Milan, Italy
Nicla Maria La Verde , Giovanna Damia , Ornella Garrone , Loretta D'Onofrio , Alessandra Fabi , Mariangela Ciccarese , Daniele Giulio Generali , Martina Nunzi , Elena Poletto , Paolo Pedrazzoli , Elisabetta Cretella , Giuseppa Scandurra , Icro Meattini , Alessandro Stefano Bertolini , Luigi Cavanna , Emanuela Romagnoli , Lorenzo Legramandi , Federica Guffanti , Barbara Bocci , Gabriella Farina
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics and Tumor Biology (Nonimmuno)
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Pharmacology/Pharmacodynamics/Pharmacogenetics
Clinical Trial Registration Number
NCT02864030
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3116)
DOI
10.1200/JCO.2019.37.15_suppl.3116
Abstract #
3116
Poster Bd #
108
Abstract Disclosures
Similar Posters
First Author: Ji-Yeon Kim
Poster
2016 Gastrointestinal Cancers Symposium
Oxaliplatin associated neurotoxicity outcomes among older adults with colorectal cancer: A population-based study.
First Author: Michael J. Raphael
First Author: Mary Wilkinson
Poster
2015 Breast Cancer Symposium
Eribulin and carboplatin in heavily pretreated patients with metastatic breast cancer: A single institution experience.
First Author: Patricia Martin Romano